PREVALÊNCIA E PERFIL EPIDEMIOLÓGICO DAS INFECÇÕES VAGINAIS
DOI:
https://doi.org/10.36557/2674-9432.2026v5n3p1128-1142Keywords:
Infecção vaginal, Vulvovaginite, Candidíase, Trichomonas VaginalisAbstract
Introduction: The vagina has a complex and diverse ecosystem known as the vaginal microbiota. An imbalance in this microbiota can lead to vaginal infections, a prevalent condition regarded as a significant public health concern due to its widespread occurrence. The most common infections are bacterial vaginosis, caused by the bacterium Gardnerella vaginalis; vulvovaginal candidiasis, triggered by the fungus Candida albicans; and trichomoniasis, caused by the protozoan Trichomonas vaginalis. Additionally, vaginal infections have a substantial impact on women's reproductive health. Epidemiological studies addressing vulvovaginitis are fundamental for the development of public health policies adressed to women, facilitating the planning of preventive and assistance programs for these conditions. Objectives: To identify the prevalence of vaginal infections in women treated at the Community Health Clinic of the University of Gurupi (UNIRG), their lifestyle habits that may favor these infections, the most common clinical presentations, and the most frequently used diagnostic methods. Methodology: This is a quantitative, cross-sectional, retrospective, and descriptive study conducted through the analysis of medical records of women treated at the Community Health Clinic of the University of Gurupi (UNIRG) between 2022 and 2024. Women aged 18 years or older who were diagnosed with vaginal infections identified by gynecological clinical examination and/or oncotic cytology were included. Women under 18 years of age, those who did not undergo the proposed examinations, and records showing vaginal microbiota within normal standards were excluded. Results: The age group with the highest prevalence of vulvovaginitis in the study was 26 to 36 years (30.76%), with isolated presence of Candida sp., Gardnerella vaginalis, Trichomonas vaginalis, as well as cases of coinfection. Conclusion: Vulvovaginitis impacts women's sexual, reproductive, and mental health. For health improvement, access to and standardization of clinical diagnosis are extremely vital for appropriate treatment of vulvovaginitis, in addition to the need for proper record-keeping in medical records.
Downloads
References
BARROS, P. F. de S.; ALMEIDA, R. S. de; LEITE, P. I. P.; CORREIA, F. de M. A. Prevalência de microrganismos identificados em esfregaços cervicovaginais de pacientes atendidas em uma unidade básica de saúde do município de Juazeiro do Norte, Ceará. Revista de Epidemiologia e Saúde Pública, [S. l.], v. 1, n. 2, 2023. DOI: 10.59788/resp.v1i2.20. Disponível em: https://respcientifica.com.br/index.php/resp/article/view/20.
CAI, Y. et al. Epidemiology and screening strategies for vulvovaginal candidiasis. 2023.
CHEN, X. et al. Prevalence and associated factors of bacterial vaginosis, vulvovaginal candidiasis and trichomoniasis. BMC Women’s Health, 2023.
COLOMBO, Arnaldo Lopes; GUIMARÃES, Thaís. Epidemiologia das infecções hematogênicas por Candida spp. Revista da Sociedade Brasileira de Medicina Tropical, v. 36, p. 599–607, 2003.
FARAJI, Roya et al. Evaluation of epidemiological, clinical, and microbiological features of vulvovaginal candidiasis. GMS Hygiene and Infection Control, v. 20, Doc15, 2025. DOI: 10.3205/dgkh000544.
FAUSTINO, Maria et al. Candida albicans: the current status regarding vaginal infections. Applied Microbiology and Biotechnology, v. 109, n. 1, p. 91, 2025. DOI: 10.1007/s00253-025-13478-2.
FERNANDES, Karolina Gabriele Gomes et al. Análise dos principais agentes microbiológicos causadores de vulvovaginites: revisão de literatura. Revista REASE, São Paulo, v. 10, n. 10, p. 1–14, out. 2024. DOI: 10.51891/rease.v10i10.15999.
JOÃO, M. A. A. et al. Frequência da vaginose bacteriana em mulheres em idade fértil dos 13 aos 40 anos. ALBA - ISFIC Research and Science Journal, [S. l.], v. 1, n. 8, p. 329–342, 2025. Disponível em: https://alba.ac.mz/index.php/alba/article/view/402.
KEIKHA, Nima; FOULADI, Behzad; YADEGARI, Mohammad H. The efficacy and safety of current treatment of vulvovaginal candidiasis: an umbrella review of systematic reviews and meta-analyses. Naunyn-Schmiedeberg’s Archives of Pharmacology, v. 398, n. 7, p. 7713–7720, jul. 2025. DOI: 10.1007/s00210-025-03852-2.
LANDERS, Daniel V. et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. American Journal of Obstetrics and Gynecology, [S. l.], v. 190, n. 4, p. 1004–1008, abr. 2004.
MUZNY, Christina A. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 CDC STI treatment guidelines. Clinical Infectious Diseases, 2022. DOI: 10.1093/cid/ciac021.
NEAL, C. M.; MARTENS, M. G. Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis. SAGE Open Medicine, v. 10, 2022. DOI: 10.1177/20503121221115201.
OLIVEIRA, Karine et al. Candidíase no cenário brasileiro atual: epidemiologia, prevenção e manejo. Brazilian Journal of Development, [S. l.], v. 8, n. 12, p. 79108–79123, 2022. DOI: 10.34117/bjdv8n12-150.
RODRIGUES, M. T. et al. Associação entre cultura de secreção vaginal, características sociodemográficas e manifestações clínicas de pacientes com diagnóstico de candidíase vulvovaginal. Revista Brasileira de Ginecologia e Obstetrícia, v. 35, p. 554–561, 2013.
SANTOS, Martha Jéssika Oliveira; ELEUTÉRIO, Renata Mirian Nunes; FONTANEZI, Cristina Tonin Beneli. Incidência de infecções por Gardnerella vaginalis e Candida sp na citologia ginecológica, Fortaleza, Brasil. Revista Interagir, Fortaleza, v. 21, n. 129, p. 20–23, 2025. DOI: https://dx.doi.org/10.12662/1809-5771RI.129.6031.p20-23.2025.
SINGH, Neha; PRASAD, Devendra; SAURABH, Kishor. Microbial spectrum of cervicovaginal discharge in symptomatic Indian women of reproductive age group. Bioinformation, v. 21, n. 4, p. 853–857, abr. 2025. DOI: 10.6026/973206300210853.
TAUR, Y.; PAMER, E. G. Microbiome mediation of infections in the cancer setting. Genome Medicine, v. 8, n. 1, p. 40, 2016.
TESHOME, T. et al. Prevalence and determinants of vaginal infections among women. Scientific Reports, 2025.
VINAGRE, Laura Moreno Montagnana et al. Vulvovaginites na atenção básica. In: Saúde da mulher. Ed. XXVI, p. 86–90, 2025. DOI: 10.59290/9059910286.
WORLD HEALTH ORGANIZATION. Bacterial vaginosis – global health overview. 2025.
YAO, Dan et al. The effects of vaginal infections on pregnancy outcomes: a retrospective cohort study in China. BMC Pregnancy and Childbirth, v. 25, p. 179, 2025. DOI: 10.1186/s12884-025-07309-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ândrea Tammiê Peixoto da Silva, Guilherme Alves Ribeiro, Karine Queiroz Poletto, Guilherme Alves Silva, Ana Catarina Veloso Sales, Nathalia Marinho Okura, Giovanna Volpi Santana Flister, Juliana Costa Parrião de Oliveira, Jordana Ribeiro da Silva, Mariana Oliveira Cordeiro, Gisele Amorim Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
